|
ZNF678 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.00592883917261E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.48510093112009E-11 |
| Normal-vs-Stage3 |
1.86373139143825E-12 |
| Normal-vs-Stage4 |
3.24218429881284E-12 |
| Stage1-vs-Stage2 |
4.859600E-01 |
| Stage1-vs-Stage3 |
1.015640E-01 |
| Stage1-vs-Stage4 |
1.716630E-01 |
| Stage2-vs-Stage3 |
6.702200E-01 |
| Stage2-vs-Stage4 |
6.816600E-01 |
| Stage3-vs-Stage4 |
9.757600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.79942735659233E-12 |
| Normal-vs-AfricanAmerican |
2.18220000000047E-05 |
| Normal-vs-Asian |
1.62140301185332E-11 |
| Caucasian-vs-AfricanAmerican |
1.956420E-01 |
| Caucasian-vs-Asian |
6.660400E-01 |
| AfricanAmerican-vs-Asian |
1.514960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.44089209850063E-13 |
| Normal-vs-Female |
3.12083692222132E-12 |
| Male-vs-Female |
3.077800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.04040109860648E-11 |
| Normal-vs-Age(41-60Yrs) |
1.63558055987778E-12 |
| Normal-vs-Age(61-80Yrs) |
2.46613840459986E-12 |
| Normal-vs-Age(81-100Yrs) |
2.210300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.042800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.114800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.466200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.720600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.074200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.992200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.388500E-04 |
| Classical-VS-Follicular |
6.609200E-01 |
| Classical-VS-Other |
2.707800E-01 |
| Classical-VS-Normal |
2.48190357154954E-11 |
| Tall-VS-Follicular |
1.500400E-02 |
| Tall-VS-Other |
8.419000E-01 |
| Tall-VS-Normal |
5.21804821573824E-15 |
| Follicular-VS-Other |
4.652200E-01 |
| Follicular-VS-Normal |
1.52560186705841E-11 |
| Other-VS-Normal |
2.844700E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.85582668624329E-12 |
| Normal-vs-N1 |
2.08943973234454E-12 |
| N0-vs-N1 |
3.224200E-01 |
|
|
